Commission on Cancer Cancer Program Practice Profile Reports (CP3R) 2016 CP3R Data Released on November 27, 2018
Site
Measure CoC Std / % EPR (%)
Cervix Radiation therapy completed within 60 days of initiation of radiation among women diagnosed with any stage of cervical cancer (Surveillance) Chemotherapy administered to cervical cancer patients who received radiation for stages IB2-IV cancer (Group 1) or with positive pelvic nodes, positive surgical margin, and/or positive parametrium (Group 2) (Surveillance) Use of brachytherapy in patients treated with primary radiation with curative intent in any stage of cervical cancer (Surveillance) Breast Breast conservation surgery rate for women with AJCC clinical stage 0, I, or II breast cancer (Surveillance) Image or palpation-guided needle biopsy (core or FNA) is performed to establish diagnosis or breast cancer (Quality Improvement) Tamoxifen of third-generation aromotase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1c or stage IB-III hormone receptor positive breast cancer (Accountability) Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with > = 4 positive regional lymph nodes (Accountability) Radiation is administered within 1 year (365 days) of diagnosis for women under the age of 70 receiving breast conservation surgery for breast cancer (accountability) Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with AJCCT1c- NO, or stage IB / III hormone receptor negative breast cancer (accountability) Colon Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability) At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer (Quality improvement) Lung Surgery is not the first course of treatment for cN2, M0 lung cases (Surveillance) Rectum Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III; or postoperative chemo and radiation are administered within 180 days of diagnosis for clinical AJCC T1- 2N0 with pathologic AJCC T3N0, T4N0, or Stage III; or treatment is considered; for patients under the age of 80 receiving resection for rectal cancer (Quality Improvement) Bladder Radical or partial cystectomy, or tri-modality therapy (local tumor dest)
CERRT
Not applicable
100.00% N-3
CERCT
Not applicable
100.00% N-4
CBRRT
Not applicable
100.00% N-2
BCS
Not applicable
100.00% N-17
nBx
4.5/80% 97.10% N-34
HT
4.4/90% 100.00% N-18
MASTRT
4.4/90% 100.00% N-1
BCSRT
4.4/90% 92.90% N-14
MAC
Not applicable
100.00% N-2
ACT
Not applicable
100.00% N-2
12RLN
4.5/85% 100.00% N-7
LNoSurg
4.5/85% 100.00%
RECRTCT
4.5/85% 100.00% N-3
BLCSTRI
Not applicable
100.00% N-1
17
2 0 1 9 A N N U A L R E P O R T
Made with FlippingBook - professional solution for displaying marketing and sales documents online